每經(jing)AI快(kuai)訊，恩華藥業(002262)6月(yue)17日(ri)晚(wan)間公(gong)(gong)告，公(gong)(gong)司董事長孫(sun)彭生(sheng)于6月(yue)16日(ri)以(yi)(yi)自有資(zi)金通過深圳證券交(jiao)易(yi)所股(gu)(gu)(gu)(gu)票交(jiao)易(yi)系(xi)統(tong)以(yi)(yi)集中(zhong)競價交(jiao)易(yi)方式(shi)增持(chi)公(gong)(gong)司A股(gu)(gu)(gu)(gu)股(gu)(gu)(gu)(gu)票23.79萬股(gu)(gu)(gu)(gu)。本次公(gong)(gong)司董事長孫(sun)彭生(sheng)增持(chi)公(gong)(gong)司股(gu)(gu)(gu)(gu)票的行為不(bu)觸及要約收(shou)購(gou)，不(bu)會(hui)導致公(gong)(gong)司股(gu)(gu)(gu)(gu)權分布不(bu)具備上市條件，不(bu)會(hui)導致公(gong)(gong)司控制權發生(sheng)變化(hua)，不(bu)會(hui)對公(gong)(gong)司治理結構及持(chi)續經(jing)營(ying)產生(sheng)重大(da)影響。